Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dose Modulation Strategy of Sonidegib for Eye-Sparing Treatment of Locally Advanced Periocular Basal Cell Carcinoma

NCT07068568 is registered in ClinicalTrials.gov with Federico II University as lead sponsor.

NCT NCT07068568
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07068568 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dose Modulation Strategy of Sonidegib for Eye-Sparing Treatment of Locally Advanced Periocular Basal Cell Carcinoma
Lead sponsor
Federico II University
Phase
Observational
Overall status
Completed
Start date
January 11, 2021
Completion date
March 20, 2024
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

basal cell cancer, basal cell carcinoma (bcc), basal cell carcinoma of the head and neck, eyelid tumor